Unaudited Interim Consolidated Statement of Operations - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Net sales	$ 1,687	$ 1,851
Cost of sales	(1,234)	(1,336)
Gross profit	453	515
Selling, general and administrative expenses	(120)	(147)
Amortization of intangible assets	(6)	(6)
Research and development expenses	(16)	(18)
Other (charges) gains, net	4	0
Foreign exchange gain (loss), net	5	(1)
Gain (loss) on disposition of businesses and assets, net	0	0
Operating profit (loss)	320	343
Equity in net earnings (loss) of affiliates	50	58
Non-operating pension and other postretirement employee benefit (expense) income	17	26
Interest expense	(31)	(33)
Interest income	1	2
Dividend income - equity investments	32	32
Other income (expense), net	(4)	4
Earnings (loss) from continuing operations before tax	385	432
Income tax (provision) benefit	(46)	(65)
Earnings (loss) from continuing operations	339	367
Earnings (loss) from operation of discontinued operations	(1)	(2)
Income tax (provision) benefit from discontinued operations	0	0
Earnings (loss) from discontinued operations	(1)	(2)
Net earnings (loss)	338	365
Net (earnings) loss attributable to noncontrolling interests	(1)	(2)
Net earnings (loss) attributable to Celanese Corporation	337	363
Amounts attributable to Celanese Corporation
Earnings (loss) from continuing operations	338	365
Earnings (loss) from discontinued operations	(1)	(2)
Net earnings (loss)	$ 337	$ 363
Earnings (loss) per common share - basic
Continuing operations	$ 2.65	$ 2.69
Discontinued operations	(0.01)	(0.02)
Net earnings (loss) - basic	2.64	2.67
Earnings (loss) per common share - diluted
Continuing operations	2.64	2.68
Discontinued operations	(0.01)	(0.02)
Net earnings (loss) - diluted	$ 2.63	$ 2.66
Weighted average shares - basic	127,542,328	135,916,446
Weighted average shares - diluted	128,215,700	136,383,735